Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. (Q40302214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

title

Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Amit Bar-Or

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Rui Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Ayman Rezk

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Hulun Li

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Canadian B Cells in MS Team

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

language of work or name

English

0 references

publication date

8 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

published in

Journal of Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

3245-3254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

5 April 2020

cites work

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Th17 cells in immunity to Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Brothers in arms: Th17 and Treg responses in Candida albicans immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Immunity to Candida albicans: Th1, Th2 cells and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Interleukin-12 receptor β1 deficiency predisposing to disseminated Coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

STAT3 mutations in the hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Immunity to infection in IL-17-deficient mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Role of interleukin-18 in host defense against disseminated Candida albicans infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Does rituximab increase the incidence of infectious complications? A narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma receiving chemotherapy containing rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Rituximab-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Pneumocystis pneumonia in patients treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Regulatory roles for cytokine-producing B cells in infection and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

IL-6: regulator of Treg/Th17 balance

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

In vivo activation of antigen-specific CD4 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Antigen presentation and T cell stimulation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

The ins and outs of MHC class II-mediated antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

How B cells capture, process and present antigens: a crucial role for cell polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

B cells as antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

IL-17A and IL-17F Expression in B Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Effects of Rituximab on the Development of Viral and Fungal Infections in Renal Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

Antigen-specific interaction between T and B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

The anti-CD20 antibody rituximab reduces the Th17 cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601572

21 January 2018

Identifiers

DOI

10.4049/JIMMUNOL.1601572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28275140%20AND%20SRC:MED&resulttype=core&format=json